Chinese life science solutions provider CapitalBio Technology has secured over 800 million yuan ($113 million) in financing ahead of a planned initial public offering (IPO) on the country’s Nasdaq-style STAR Market.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
